Genome Engineering Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Technology (CRISPR, TALEN, ZFN, Antisense, Others), By Delivery Method (Ex-Vivo v/s In-Vivo), By Application (Cell Line Engineering, Genetic Engineering, Diagnostic Applications, Drug Discovery & Development, Others), By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutions, Others), By Region

  • Industry : Healthcare
  • Pages : NA
  • Published Date : NA
Customization Enquiry

Buy Now

Summary

Report Description

The global genome engineering market is anticipated to witness an impressive growth during the forecast period. Genome engineering is a process that allows for the insertion, deletion, modification, or replacement of DNA in a living organism's genome. As a result of this, the technique can be used for development of new therapies, treatment and drugs for different therapeutic areas especially the chronic diseases. Various academic & research institutions and biotechnology & pharmaceutical companies are focusing and using this technology for development of novel therapies. For instance, Synthego Corporation introduced the Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Pioneers Program in October 2017. Using this Clustered Regularly Interspaced Short Palindromic Repeats, researchers are focusing on discovering cures for cancer and other disease areas.

Increasing Development of Novel Technologies

Various companies and academic & research institutions are using genome engineering technique for the development of new therapies and treatment. This is not only helping them improvise their status but also improving the market positioning of various companies and helping them have an edge over other players operating in the market. For instance, Sangamo Therapeutics, Inc.'s SB-FIX, a zinc finger nuclease (ZFN)-mediated in vivo genome editing treatment for hemophilia B, recieved clinical trial authorization (CTA) from the U.K.'s Medicines and Healthcare Products Regulatory Agency (MHRA) in February 2018. Similarly, the first Cas9 enzyme variation, which reduces the off-target effects in CRISPR genome editing, was introduced in 2017 by Integrated DNA Technologies, Inc. This represented a significant step towards the therapeutic application of CRISPR.

Increasing Funding and Investments for Research and Development

The increasing funding and investments in the study and development of new genetic engineering technologies is expected to create lucrative opportunities for the growth of genome engineering market in the coming years. For instance, the United States National Institutes of Health (NIH) stated in January 2018 that it would be supporting genome editing research through its new program called Somatic Cell Genome Editing. Under this program grants will be provided to researchers across Canada and United States to conduct research related to genome editing.

Growing Application Areas of Genomics

The applications of genomics have significantly increased over the years across different fields including forensics, genetic disorders, drug discovery, agriculture among others. The advent of Next Generation sequencing has increased the application of genomics across the fields of forensics. Future trends in genome engineering includes its application in the field of nutraceuticals, marine engineering among others. Personalized nutrition and precision medicine are another field wherein the demand for genome engineering is expected to increase. A lot of research and clinical trials are being conducted across different parts of the globe to identify more areas wherein genomic engineering is used. This in turn will create lucrative opportunities for the growth of global genomic engineering market over the next few years.


DOWNLOAD FREE SAMPLE REPORT

Market Segmentation

The Global Genome Engineering market is segmented into by technology, by delivery method, by application, by end user, by region. Based on technology, the market can be categorized into CRISPR, TALEN, ZFN, Antisense, Others. Based on delivery method, the market is divided into Ex-Vivo v/s In-Vivo. Based on application, the market can be fragmented into Cell Line Engineering, Genetic Engineering, Diagnostic Applications, Drug Discovery & Development, Others. Based on by end user, the market can be segmented into Pharmaceutical & Biotechnology Companies, Academic & Research Institutions, Others. Regionally, North America dominated the market among Europe, Asia Pacific, South America and Middle East & Africa. United States holds the largest market among all the countries across the globe. This can be ascribed to the increasing research & development expenditure in the country for development of new therapies and treatment. In 2021, the Federal Funds allocation for research and development in United States was around USD185.41 billion.

Market Players

Merck KGaA, Sangamo Therapeutics, Inc., Genscript Biotech Corp, CRISPR Therapeutics AG, Editas Medicine, Inc., Precision BioSciences, Inc., Horizon Discovery Group plc, Lonza Group Ltd., OriGene Technologies, Inc., Transposagen Biopharmaceuticals, Inc. are the leading players operating in the Global Genome Engineering Market. Various companies operating in the market are focusing on research & development activities for development of therapies or drugs using genomic engineering. For instance, in October 2021, Merck KGaA licensed its patented CRISPR-Cas9 technology Cellecta for the development of next-generation treatments. The technology has helped researchers and scientists across the globe in advancing treatments for the different forms of cancer, blood related genetic disorders, among others.

Attribute

Details

Base Year

2021

Historic Data

2017 – 2020

Estimated Year

2022

Forecast Period

2023 – 2027

Quantitative Units

Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027

Report coverage

Revenue forecast, volume forecast, company share, competitive landscape, growth factors, and trends

Segments covered

·         By Technology

·         By Delivery Method

·         By Application

·         By End User

Regional scope

North America; Asia Pacific; Europe; South America; Middle East & Africa

Country scope

United States; Canada; Mexico; China; India; Japan; South Korea; Australia; Germany; France; United Kingdom; Spain; Italy; Brazil; Argentina; Colombia; South Africa; Saudi Arabia; UAE

Key companies profiled

Merck KGaA, Sangamo Therapeutics, Inc., Genscript Biotech Corp, CRISPR Therapeutics AG, Editas Medicine, Inc., Precision BioSciences, Inc., Horizon Discovery Group plc, Lonza Group Ltd., OriGene Technologies, Inc., Transposagen Biopharmaceuticals, Inc.

Customization scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


Report Scope:

In this report, Global Genome Engineering market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Genome Engineering Market, By Technology:
    • CRISPR
    • TALEN
    • ZFN
    • Antisense
    • Others
  • Genome Engineering Market, By Delivery Method:
    • Ex-Vivo
    • In-Vivo

·         Genome Engineering Market, By Application:

o   Cell Line Engineering

o   Genetic Engineering

o   Diagnostic Applications

o   Drug Discovery & Development

o   Others

·         Genome Engineering Market, By End User:

o   Pharmaceutical & Biotechnology Companies

o   Academic & Research Institutions

o   Others  

  • Genome Engineering Market, By Region:
    • North America
      • United States
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • United Kingdom
      • Spain
      • Italy
    • Asia-Pacific
      • China
      • India
      • Japan
      • South Korea
      • Australia
    • South America
      • Brazil
      • Argentina
      • Colombia
    • Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Genome Engineering market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Global Genome Engineering market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1.    Product Overview

2.    Research Methodology

3.    Executive Summary

4.    Impact of COVID-19 on Global Genome Engineering Market

5.    Voice of Customer

6.    Global Genome Engineering Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Technology (CRISPR, TALEN, ZFN, Antisense, Others)

6.2.2.     By Delivery Method (Ex-Vivo v/s In-Vivo)

6.2.3.     By Application (Cell Line Engineering, Genetic Engineering, Diagnostic Applications, Drug Discovery & Development, Others)

6.2.4.     By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutions, Others)

6.2.5.     By Company (2021)

6.2.6.     By Region

6.3.  Product Market Map

7.    North America Genome Engineering Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Technology

7.2.2.     By Delivery Method

7.2.3.     By Application

7.2.4.     By End User

7.2.5.     By Country

7.3.  North America: Country Analysis

7.3.1.     United States Genome Engineering Market Outlook

7.3.1.1.         Market Size & Forecast

7.3.1.1.1.             By Value

7.3.1.2.         Market Share & Forecast

7.3.1.2.1.             By Technology

7.3.1.2.2.             By Delivery Method

7.3.1.2.3.             By Application

7.3.1.2.4.             By End User

7.3.2.     Mexico Genome Engineering Market Outlook

7.3.2.1.         Market Size & Forecast

7.3.2.1.1.             By Value

7.3.2.2.         Market Share & Forecast

7.3.2.2.1.             By Technology

7.3.2.2.2.             By Delivery Method

7.3.2.2.3.             By Application

7.3.2.2.4.             By End User

7.3.3.     Canada Genome Engineering Market Outlook

7.3.3.1.         Market Size & Forecast

7.3.3.1.1.             By Value

7.3.3.2.         Market Share & Forecast

7.3.3.2.1.             By Technology

7.3.3.2.2.             By Delivery Method

7.3.3.2.3.             By Application

7.3.3.2.4.             By End User

8.    Europe Genome Engineering Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Technology

8.2.2.     By Delivery Method

8.2.3.     By Application

8.2.4.     By End User

8.2.5.     By Country

8.3.  Europe: Country Analysis

8.3.1.     France Genome Engineering Market Outlook

8.3.1.1.         Market Size & Forecast

8.3.1.1.1.             By Value

8.3.1.2.         Market Share & Forecast

8.3.1.2.1.             By Technology

8.3.1.2.2.             By Delivery Method

8.3.1.2.3.             By Application

8.3.1.2.4.             By End User

8.3.2.     Germany Genome Engineering Market Outlook

8.3.2.1.         Market Size & Forecast

8.3.2.1.1.             By Value

8.3.2.2.         Market Share & Forecast

8.3.2.2.1.             By Technology

8.3.2.2.2.             By Delivery Method

8.3.2.2.3.             By Application

8.3.2.2.4.             By End User

8.3.3.     United Kingdom Genome Engineering Market Outlook

8.3.3.1.         Market Size & Forecast

8.3.3.1.1.             By Value

8.3.3.2.         Market Share & Forecast

8.3.3.2.1.             By Service Type

8.3.3.2.2.             By Gene Type

8.3.3.2.3.             By Application

8.3.3.2.4.             By End User

8.3.4.     Italy Genome Engineering Market Outlook

8.3.4.1.         Market Size & Forecast

8.3.4.1.1.             By Value

8.3.4.2.         Market Share & Forecast

8.3.4.2.1.             By Technology

8.3.4.2.2.             By Delivery Method

8.3.4.2.3.             By Application

8.3.4.2.4.             By End User

8.3.5.     Spain Genome Engineering Market Outlook

8.3.5.1.         Market Size & Forecast

8.3.5.1.1.             By Value

8.3.5.2.         Market Share & Forecast

8.3.5.2.1.             By Technology

8.3.5.2.2.             By Delivery Method

8.3.5.2.3.             By Application

8.3.5.2.4.             By End User

9.    Asia-Pacific Genome Engineering Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Technology

9.2.2.     By Delivery Method

9.2.3.     By Application

9.2.4.     By End User

9.2.5.     By Country

9.3.  Asia-Pacific: Country Analysis

9.3.1.     China Genome Engineering Market Outlook

9.3.1.1.         Market Size & Forecast

9.3.1.1.1.             By Value

9.3.1.2.         Market Share & Forecast

9.3.1.2.1.             By Technology

9.3.1.2.2.             By Delivery Method

9.3.1.2.3.             By Application

9.3.1.2.4.             By End User

9.3.2.     India Genome Engineering Market Outlook

9.3.2.1.         Market Size & Forecast

9.3.2.1.1.             By Value

9.3.2.2.         Market Share & Forecast

9.3.2.2.1.             By Technology

9.3.2.2.2.             By Delivery Method

9.3.2.2.3.             By Application

9.3.2.2.4.             By End User

9.3.3.     South Korea Genome Engineering Market Outlook

9.3.3.1.         Market Size & Forecast

9.3.3.1.1.             By Value

9.3.3.2.         Market Share & Forecast

9.3.3.2.1.             By Technology

9.3.3.2.2.             By Delivery Method

9.3.3.2.3.             By Application

9.3.3.2.4.             By End User

9.3.4.     Japan Genome Engineering Market Outlook

9.3.4.1.         Market Size & Forecast

9.3.4.1.1.             By Value

9.3.4.2.         Market Share & Forecast

9.3.4.2.1.             By Technology

9.3.4.2.2.             By Delivery Method

9.3.4.2.3.             By Application

9.3.4.2.4.             By End User

9.3.5.     Australia Genome Engineering Market Outlook

9.3.5.1.         Market Size & Forecast

9.3.5.1.1.             By Value

9.3.5.2.         Market Share & Forecast

9.3.5.2.1.             By Technology

9.3.5.2.2.             By Delivery Method

9.3.5.2.3.             By Application

9.3.5.2.4.             By End User

10.  South America Genome Engineering Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Technology

10.2.2.  By Delivery Method

10.2.3.  By Application

10.2.4.  By End User

10.2.5.  By Country

10.3.              South America: Country Analysis

10.3.1.  Brazil Genome Engineering Market Outlook

10.3.1.1.      Market Size & Forecast

10.3.1.1.1.           By Value

10.3.1.2.      Market Share & Forecast

10.3.1.2.1.           By Technology

10.3.1.2.2.           By Delivery Method

10.3.1.2.3.           By Application

10.3.1.2.4.           By End User

10.3.2.  Argentina Genome Engineering Market Outlook

10.3.2.1.      Market Size & Forecast

10.3.2.1.1.           By Value

10.3.2.2.      Market Share & Forecast

10.3.2.2.1.           By Technology

10.3.2.2.2.           By Delivery Method

10.3.2.2.3.           By Application

10.3.2.2.4.           By End User

10.3.3.  Colombia Genome Engineering Market Outlook

10.3.3.1.      Market Size & Forecast

10.3.3.1.1.           By Value

10.3.3.2.      Market Share & Forecast

10.3.3.2.1.           By Technology

10.3.3.2.2.           By Delivery Method

10.3.3.2.3.           By Application

10.3.3.2.4.           By End User

11.  Middle East and Africa Genome Engineering Market Outlook

11.1.              Market Size & Forecast

11.1.1.  By Value

11.2.              Market Share & Forecast

11.2.1.  By Technology

11.2.2.  By Delivery Method

11.2.3.  By Application

11.2.4.  By End User

11.2.5.  By Country

11.3.              MEA: Country Analysis

11.3.1.  South Africa Genome Engineering Market Outlook

11.3.1.1.      Market Size & Forecast

11.3.1.1.1.           By Value

11.3.1.2.      Market Share & Forecast

11.3.1.2.1.           By Technology

11.3.1.2.2.           By Delivery Method

11.3.1.2.3.           By Application

11.3.1.2.4.           By End User

11.3.2.  Saudi Arabia Genome Engineering Market Outlook

11.3.2.1.      Market Size & Forecast

11.3.2.1.1.           By Value

11.3.2.2.      Market Share & Forecast

11.3.2.2.1.           By Technology

11.3.2.2.2.           By Delivery Method

11.3.2.2.3.           By Application

11.3.2.2.4.           By End User

11.3.3.  UAE Genome Engineering Market Outlook

11.3.3.1.      Market Size & Forecast

11.3.3.1.1.           By Value

11.3.3.2.      Market Share & Forecast

11.3.3.2.1.           By Technology

11.3.3.2.2.           By Delivery Method

11.3.3.2.3.           By Application

11.3.3.2.4.           By End User

12.  Market Dynamics

12.1.              Drivers

12.2.              Challenges

13.  Market Trends & Developments

13.1.              Recent Developments

13.2.              Product Launches

13.3.              Mergers & Acquisitions

14.  Porter’s Five Forces Analysis

15.  PESTLE Analysis

16.  Competitive Landscape (Inclusive of SWOT Analysis of Players Profiled)

16.1.              Merck KGaA

16.2.              Sangamo Therapeutics, Inc.

16.3.              Genscript Biotech Corp

16.4.              CRISPR Therapeutics AG

16.5.              Editas Medicine, Inc.

16.6.              Precision BioSciences, Inc.

16.7.              Horizon Discovery Group plc

16.8.              Lonza Group Ltd.

16.9.              OriGene Technologies, Inc.

16.10.            Transposagen Biopharmaceuticals, Inc.

17.  Strategic Recommendations

Figures and Tables

Frequently asked questions

down-arrow

Increasing development of novel technologies in genome engineering and increasing funding and investments for research and development of new genetic engineering technologies are expected to drive the market growth.

down-arrow

Merck KGaA, Sangamo Therapeutics, Inc., Genscript Biotech Corp, CRISPR Therapeutics AG, Editas Medicine, Inc., Precision BioSciences, Inc., Horizon Discovery Group plc, Lonza Group Ltd., OriGene Technologies, Inc., Transposagen Biopharmaceuticals, Inc. are the leading players operating in the global genome engineering market.

down-arrow

CISPR is the leading technology type segment in the market for the forecast period.

down-arrow

North America is estimated to demonstrate significant growth during the forecast period.

Related Reports

profile

Sakshi Bajaal

Business Consultant
Press Release

Genome Engineering Market to be dominated by CRISPR Technique through 2027

Sep, 2022

Growing applications of genomics in different application areas such as human genetic disorders, agriculture, drug discovery, etc. is expected to drive the growth of global genome engineering market

Why Choose Us